Johannes Mofors
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Johannes Mofors has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Marie Wahren-Herlenius
Division of Rheumatology, Department of Medicine, Karolinska Institutet , Stockholm
15 shared publications Albin Björk
Division of Rheumatology, Department of Medicine, Karolinska Institutet , Stockholm
7 shared publications- Gunnel Nordmark
Dept of Medical Sciences, Rheumatology, Uppsala University, Sweden
7 shared publications - Marika Kvarnström
Rheumatology Unity, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
5 shared publications Per Eriksson
Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University , Linköping
5 shared publications- Helena Forsblad-D’eLia
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
4 shared publications
Latest Publications
- Open Access
- 15 July 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- p. 1-9
Patterns of migration underlie the increasing incidence of Kawasaki disease in Sweden from 1987 to 2018: a cohort study
To define the demographics of Kawasaki disease (KD) in Sweden during a 32 year period. Routinely collected administrative and healthcare data from nationwide Swedish registers were collected for this population-based cohort study. The case definition was individuals under the age of 25 and diagnosed with KD from 1987 to 2018. Main measures included incidence rate, year and month of diagnosis, sex and age at diagnosis, patient's and parents' world region of birth, and home county. In total, 1917 cases were identified. Median age at diagnosis was 2.82 years (interquartile range 1.47-5.13) and 62% were males. Relative incidence rates in winter [1.29, 95% confidence interval (CI) 1.14-1.47] and spring (1.21, 95% CI 1.07-1.38) were higher than in the reference season (summer), while incidence over the study period varied geographically across counties, with no discernible pattern. The incidence rate in the population increased during the 32 year period from 3.6 to 12.1 (95% CI 9.1-15.2) per 100 000 under-5-year-olds during the last 5 years of the study. This increase related mainly to cases with one or two parents of non-Swedish, predominantly Asian and African, origin. Two significant peaks in incidence rates in 2008 and 2015 were also observed, mainly relating to cases with two Swedish-born parents. Our study confirms the age and sex distribution as well as seasonal variation and occurrence of peak years of KD. Migration patterns were associated with increasing numbers of KD, which is important to consider for healthcare planning and for defining risk groups.
- 15 July 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- p. 1-9
Open AccessPatterns of migration underlie the increasing incidence of Kawasaki disease in Sweden from 1987 to 2018: a cohort study
To define the demographics of Kawasaki disease (KD) in Sweden during a 32 year period. Routinely collected administrative and healthcare data from nationwide Swedish registers were collected for this population-based cohort study. The case definition was individuals under the age of 25 and diagnosed with KD from 1987 to 2018. Main measures included incidence rate, year and month of diagnosis, sex and age at diagnosis, patient's and parents' world region of birth, and home county. In total, 1917 cases were identified. Median age at diagnosis was 2.82 years (interquartile range 1.47-5.13) and 62% were males. Relative incidence rates in winter [1.29, 95% confidence interval (CI) 1.14-1.47] and spring (1.21, 95% CI 1.07-1.38) were higher than in the reference season (summer), while incidence over the study period varied geographically across counties, with no discernible pattern. The incidence rate in the population increased during the 32 year period from 3.6 to 12.1 (95% CI 9.1-15.2) per 100 000 under-5-year-olds during the last 5 years of the study. This increase related mainly to cases with one or two parents of non-Swedish, predominantly Asian and African, origin. Two significant peaks in incidence rates in 2008 and 2015 were also observed, mainly relating to cases with two Swedish-born parents. Our study confirms the age and sex distribution as well as seasonal variation and occurrence of peak years of KD. Migration patterns were associated with increasing numbers of KD, which is important to consider for healthcare planning and for defining risk groups.
- Open Access
- 16 June 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- p. 1-6
Clinical and histopathological features of a population-based cohort of 95 consecutive patients with immunoglobulin G4-related disease in Stockholm, Sweden, during a five-year period
To describe the epidemiology, organ involvement, histopathological patterns, and clinical management of immunoglobulin G4-related disease (IgG4-RD) in Stockholm County, Sweden. Patients with an International Classification of Diseases, 10th revision, Swedish Edition (ICD-10-SE) diagnosis of IgG4-RD recorded between 2019 and 2023 were identified from the Swedish National Patient Register, encompassing all diagnoses recorded in inpatient and specialist outpatient care. Clinical data, laboratory results, histopathology reports, and treatment information were obtained through systematic medical record review. In total, 112 patients with a registered IgG4-RD diagnosis were identified, of which 95 diagnoses were confirmed after medical record review. The cohort was predominantly male (68%), and 60% had disease involvement of two or more organs. Elevated serum IgG4 was present in 71% of patients. The pancreas, hepatobiliary system, and kidneys were the most frequently affected organs, while salivary gland involvement was comparatively uncommon. Among patients who underwent biopsy (76%), a majority showed histopathological features supportive of IgG4-RD, although only a minority fulfilled multiple histopathological criteria. Comorbidities at the time of diagnosis were similar to those observed in the general older population, although an elevated prevalence of nasal polyposis and asthma was observed. Most patients received systemic glucocorticoids, either alone or in combination with rituximab. Overall, the prognosis was favourable, with high remission rates. IgG4-RD in Stockholm County shows a pancreatohepatobiliary-renal dominant pattern, with relatively few glandular cases compared to Asian and US cohorts. Histopathological confirmation was supportive in most biopsied patients, although many affected organs were not biopsied.
- 16 June 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- p. 1-6
Open AccessClinical and histopathological features of a population-based cohort of 95 consecutive patients with immunoglobulin G4-related disease in Stockholm, Sweden, during a five-year period
To describe the epidemiology, organ involvement, histopathological patterns, and clinical management of immunoglobulin G4-related disease (IgG4-RD) in Stockholm County, Sweden. Patients with an International Classification of Diseases, 10th revision, Swedish Edition (ICD-10-SE) diagnosis of IgG4-RD recorded between 2019 and 2023 were identified from the Swedish National Patient Register, encompassing all diagnoses recorded in inpatient and specialist outpatient care. Clinical data, laboratory results, histopathology reports, and treatment information were obtained through systematic medical record review. In total, 112 patients with a registered IgG4-RD diagnosis were identified, of which 95 diagnoses were confirmed after medical record review. The cohort was predominantly male (68%), and 60% had disease involvement of two or more organs. Elevated serum IgG4 was present in 71% of patients. The pancreas, hepatobiliary system, and kidneys were the most frequently affected organs, while salivary gland involvement was comparatively uncommon. Among patients who underwent biopsy (76%), a majority showed histopathological features supportive of IgG4-RD, although only a minority fulfilled multiple histopathological criteria. Comorbidities at the time of diagnosis were similar to those observed in the general older population, although an elevated prevalence of nasal polyposis and asthma was observed. Most patients received systemic glucocorticoids, either alone or in combination with rituximab. Overall, the prognosis was favourable, with high remission rates. IgG4-RD in Stockholm County shows a pancreatohepatobiliary-renal dominant pattern, with relatively few glandular cases compared to Asian and US cohorts. Histopathological confirmation was supportive in most biopsied patients, although many affected organs were not biopsied.
- Open Access
- 28 March 2025
- Published by Wiley in Acta Paediatrica
- Vol. 114 (8) , 1990-1999
Swedish Nationwide Study Found That Prematurity Was Associated With Kawasaki Disease
Aim: Our aim was to identify perinatal and parental risk factors for Kawasaki disease (KD). Methods: Swedish patient and population registers were used to identify children diagnosed with KD and unaffected matched controls from 1987 to 2018. Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) following exposure to perinatal and parental factors. Results: We identified 1645 cases (61% male) and 15 463 matched controls. The median age of KD diagnoses was 2.6 years. Preterm birth was significantly associated with increased odds of developing KD (OR 1.24, 95% CI 1.01–1.53), particularly for children diagnosed before 1 year of age (OR 1.82, 95% CI 1.15–2.86). Prenatal maternal smoking was also associated with diagnoses before 1 year of age and the risk was increased in males if their mothers were 35 years of age or older at the time of delivery. The risk was higher among children of Asian or African descent. Perinatal factors had a higher impact on the risk of KD in children with Asian parents. Conclusion: Prematurity was significantly associated with an increased risk of developing KD. Other risks were prenatal maternal smoking, advanced maternal age, and being of Asian or African descent.
- 28 March 2025
- Published by Wiley in Acta Paediatrica
- Vol. 114 (8) , 1990-1999
Open AccessSwedish Nationwide Study Found That Prematurity Was Associated With Kawasaki Disease
Aim: Our aim was to identify perinatal and parental risk factors for Kawasaki disease (KD). Methods: Swedish patient and population registers were used to identify children diagnosed with KD and unaffected matched controls from 1987 to 2018. Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) following exposure to perinatal and parental factors. Results: We identified 1645 cases (61% male) and 15 463 matched controls. The median age of KD diagnoses was 2.6 years. Preterm birth was significantly associated with increased odds of developing KD (OR 1.24, 95% CI 1.01–1.53), particularly for children diagnosed before 1 year of age (OR 1.82, 95% CI 1.15–2.86). Prenatal maternal smoking was also associated with diagnoses before 1 year of age and the risk was increased in males if their mothers were 35 years of age or older at the time of delivery. The risk was higher among children of Asian or African descent. Perinatal factors had a higher impact on the risk of KD in children with Asian parents. Conclusion: Prematurity was significantly associated with an increased risk of developing KD. Other risks were prenatal maternal smoking, advanced maternal age, and being of Asian or African descent.
- Open Access
- 18 December 2024
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (7) , 4341-4346
A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease
Objectives: To calculate a polygenic risk score (PRS) based on single nucleotide variants (SNVs) previously associated with primary Sjögren’s disease (SjD) with genome-wide significance and determine the genetic risk for SjD stratified by antibodies, sex and age at diagnosis. Methods: Patients with SjD (n = 1065) were genotyped using Illumina OmniExpressExome chip. Control genotype data were available (n = 7742). Two PRSs were constructed, one including HLA gene variants (n = 21 SNVs), and one without HLA (n = 18 SNVs). High PRS quartile (Q4) individuals were compared with low PRS (Q1–3). Results: A high PRS was associated with SSA antibody-positive SjD (OR 9.16, 95% CI 7.75–10.85, P = 3.7 × 10−146), and strengthened in SjD positive for both SSA/SSB antibodies (OR 13.67, 95% CI 10.88–17.32, P = 4.6 × 10−108). High PRS classified SSA/SSB antibody-positive SjD with very good accuracy (AUC 0.86). PRS without HLA showed a weaker association with SSA/SSB positive SjD (OR 2.09, 95% CI 1.71–2.55, P = 6.4 × 10−13). Antibody negative SjD displayed a PRS similar to controls. Patients in the high PRS quartile were significantly younger at diagnosis, 48.9 ± 14.9 vs 53.4 ± 13.4 years in the low PRS quartiles (Q1–3), P = 2.2 × 10−6, and presented higher frequencies of ANA, SSA and SSA/SSB antibodies, P < 1 × 10−5. Conclusion: A high PRS is associated with SSA/SSB antibody positivity and early disease onset, both largely attributed to the weight of the HLA alleles. Integration of PRS with other biomarkers applied to clinical phenotypes could be a useful tool for disease risk stratification and treatment decisions.
- 18 December 2024
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (7) , 4341-4346
Open AccessA high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease
Objectives: To calculate a polygenic risk score (PRS) based on single nucleotide variants (SNVs) previously associated with primary Sjögren’s disease (SjD) with genome-wide significance and determine the genetic risk for SjD stratified by antibodies, sex and age at diagnosis. Methods: Patients with SjD (n = 1065) were genotyped using Illumina OmniExpressExome chip. Control genotype data were available (n = 7742). Two PRSs were constructed, one including HLA gene variants (n = 21 SNVs), and one without HLA (n = 18 SNVs). High PRS quartile (Q4) individuals were compared with low PRS (Q1–3). Results: A high PRS was associated with SSA antibody-positive SjD (OR 9.16, 95% CI 7.75–10.85, P = 3.7 × 10−146), and strengthened in SjD positive for both SSA/SSB antibodies (OR 13.67, 95% CI 10.88–17.32, P = 4.6 × 10−108). High PRS classified SSA/SSB antibody-positive SjD with very good accuracy (AUC 0.86). PRS without HLA showed a weaker association with SSA/SSB positive SjD (OR 2.09, 95% CI 1.71–2.55, P = 6.4 × 10−13). Antibody negative SjD displayed a PRS similar to controls. Patients in the high PRS quartile were significantly younger at diagnosis, 48.9 ± 14.9 vs 53.4 ± 13.4 years in the low PRS quartiles (Q1–3), P = 2.2 × 10−6, and presented higher frequencies of ANA, SSA and SSA/SSB antibodies, P < 1 × 10−5. Conclusion: A high PRS is associated with SSA/SSB antibody positivity and early disease onset, both largely attributed to the weight of the HLA alleles. Integration of PRS with other biomarkers applied to clinical phenotypes could be a useful tool for disease risk stratification and treatment decisions.
- Open Access
Cigarette smoking patterns preceding primary Sjögren’s syndrome
Background Cigarette smoking is a well-established risk factor for several autoimmune diseases, but its role in primary Sjögren’s syndrome (pSS) remains unclear. Here, we investigated the association between cigarette smoking and subsequent development of pSS. Methods Information on smoking habits was collected from lifestyle habit questionnaires of patients with pSS (n=815) and a matched control group (n=4425) for a case–control study. Differences in smoking exposure were analysed by conditional logistic regression. Potential interactions between smoking and risk-associated human leucocyte antigens (HLA) were assessed by multivariate regression. Results The fraction of patients with pSS having ever smoked prior to diagnosis was lower than in controls (OR 0.67, 95% CI 0.55 to 0.81). Current smoking at diagnosis was also less prevalent in cases (OR 0.37, 95% CI 0.26 to 0.53). However, period prevalence of smoking during early adulthood was not statistically different from controls (OR 0.89, 95% CI 0.66 to 1.22) but markedly decreased over time. This was partly due to patients being more prone to stop smoking, starting already 30 years prior to diagnosis (OR 2.01, 95% CI 1.22 to 3.30). Smoking patterns were also stratified by autoantibody status, yielding similar estimates. No interaction effects between HLA-DRB1 haplotypes and smoking were observed. Conclusion The observed smoking patterns indicate that individuals who develop pSS smoke equally much as the general population during early life but are then more prone to stop. The data can be interpreted as smoking conferring protective effects, or reflecting early symptoms of pSS that affect smoking habits, emphasising the slow, progressive development of the disease.
Open AccessCigarette smoking patterns preceding primary Sjögren’s syndrome
Background Cigarette smoking is a well-established risk factor for several autoimmune diseases, but its role in primary Sjögren’s syndrome (pSS) remains unclear. Here, we investigated the association between cigarette smoking and subsequent development of pSS. Methods Information on smoking habits was collected from lifestyle habit questionnaires of patients with pSS (n=815) and a matched control group (n=4425) for a case–control study. Differences in smoking exposure were analysed by conditional logistic regression. Potential interactions between smoking and risk-associated human leucocyte antigens (HLA) were assessed by multivariate regression. Results The fraction of patients with pSS having ever smoked prior to diagnosis was lower than in controls (OR 0.67, 95% CI 0.55 to 0.81). Current smoking at diagnosis was also less prevalent in cases (OR 0.37, 95% CI 0.26 to 0.53). However, period prevalence of smoking during early adulthood was not statistically different from controls (OR 0.89, 95% CI 0.66 to 1.22) but markedly decreased over time. This was partly due to patients being more prone to stop smoking, starting already 30 years prior to diagnosis (OR 2.01, 95% CI 1.22 to 3.30). Smoking patterns were also stratified by autoantibody status, yielding similar estimates. No interaction effects between HLA-DRB1 haplotypes and smoking were observed. Conclusion The observed smoking patterns indicate that individuals who develop pSS smoke equally much as the general population during early life but are then more prone to stop. The data can be interpreted as smoking conferring protective effects, or reflecting early symptoms of pSS that affect smoking habits, emphasising the slow, progressive development of the disease.
- Open Access
- 1 August 2020
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (8) , e95
Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
- 1 August 2020
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (8) , e95
Open AccessEffects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
- Open Access
- 27 February 2020
- Published by Wiley in Journal of Internal Medicine
- Vol. 287 (5) , 475-492
Environmental factors in the pathogenesis of primary Sjögren's syndrome
Primary Sjögren's syndrome (SS) is a systemic autoimmune disease in which exocrine organs, primarily the salivary and lacrimal glands, are targets of chronic inflammation, leading to severe dryness of eyes and mouth. Fatigue and arthralgia are also common, and extraglandular manifestations involving the respiratory, nervous and vascular systems occur in a subset of patients. Persistent activation of the type I interferon system, and autoreactive B and T cells with production of disease‐associated autoantibodies are central to the pathogenesis. Genetic polymorphisms that associate with an increased risk of SS have been described, though the risk‐increase contributed by the respective variant is generally low. It is thus becoming increasingly clear that genetics cannot alone account for the development of SS and that other, presumably exogenous, factors must play a critical role. Relatively few studies have investigated exposure to potential risk factors prior to SS disease onset. Rather, many factors have been studied in prevalent cases. In this review, we summarize current literature on exogenous factors in the pathogenesis of SS including infections, hormones, smoking, solvents and additional compounds. We delineate for which factors there is current evidence of increased disease risk, and for which our present knowledge is confined to suggesting their role in SS pathogenesis. Finally, we outline future perspectives in the continued search for environmental risk factors for SS, a research area of great importance considering the possibilities for preventive measures.
- 27 February 2020
- Published by Wiley in Journal of Internal Medicine
- Vol. 287 (5) , 475-492
Open AccessEnvironmental factors in the pathogenesis of primary Sjögren's syndrome
Primary Sjögren's syndrome (SS) is a systemic autoimmune disease in which exocrine organs, primarily the salivary and lacrimal glands, are targets of chronic inflammation, leading to severe dryness of eyes and mouth. Fatigue and arthralgia are also common, and extraglandular manifestations involving the respiratory, nervous and vascular systems occur in a subset of patients. Persistent activation of the type I interferon system, and autoreactive B and T cells with production of disease‐associated autoantibodies are central to the pathogenesis. Genetic polymorphisms that associate with an increased risk of SS have been described, though the risk‐increase contributed by the respective variant is generally low. It is thus becoming increasingly clear that genetics cannot alone account for the development of SS and that other, presumably exogenous, factors must play a critical role. Relatively few studies have investigated exposure to potential risk factors prior to SS disease onset. Rather, many factors have been studied in prevalent cases. In this review, we summarize current literature on exogenous factors in the pathogenesis of SS including infections, hormones, smoking, solvents and additional compounds. We delineate for which factors there is current evidence of increased disease risk, and for which our present knowledge is confined to suggesting their role in SS pathogenesis. Finally, we outline future perspectives in the continued search for environmental risk factors for SS, a research area of great importance considering the possibilities for preventive measures.
- 1 February 2020
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (2) , 307-308
Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies
- 1 February 2020
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (2) , 307-308
Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies
- Open Access
Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren’s syndrome
Objective: Standard assessment of interferon (IFN) system activity in systemic rheumatic diseases depends on the availability of RNA samples. In this study, we describe and evaluate alternative methods using plasma, serum and DNA samples, exemplified in the IFN-driven disease primary Sjögren’s syndrome (pSS). Methods: Patients with pSS seropositive or negative for anti-SSA/SSB and controls were included. Protein-based IFN (pIFN) scores were calculated from levels of PD-1, CXCL9 and CXCL10. DNA methylation-based (DNAm) IFN scores were calculated from DNAm levels at RSAD2, IFIT1 and IFI44L . Scores were compared with mRNA-based IFN scores measured by quantitative PCR (qPCR), Nanostring or RNA sequencing (RNAseq). Results: mRNA-based IFN scores displayed strong correlations between B cells and monocytes (r=0.93 and 0.95, p<0.0001) and between qPCR and Nanostring measurements (r=0.92 and 0.92, p<0.0001). The pIFN score in plasma and serum was higher in patients compared with controls (p<0.0001) and correlated well with mRNA-based IFN scores (r=0.62–0.79, p<0.0001), as well as with each other (r=0.94, p<0.0001). Concordance of classification as ‘high’ or ‘low’ IFN signature between the pIFN score and mRNA-based IFN scores ranged from 79.5% to 88.6%, and the pIFN score was effective at classifying patients and controls (area under the curve, AUC=0.89–0.93, p<0.0001). The DNAm IFN score showed strong correlation to the RNAseq IFN score (r=0.84, p<0.0001) and performed well in classifying patients and controls (AUC=0.96, p<0.0001). Conclusions: We describe novel methods of assessing IFN system activity in plasma, serum or DNA samples, which may prove particularly valuable in studies where RNA samples are not available.
Open AccessProtein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren’s syndrome
Objective: Standard assessment of interferon (IFN) system activity in systemic rheumatic diseases depends on the availability of RNA samples. In this study, we describe and evaluate alternative methods using plasma, serum and DNA samples, exemplified in the IFN-driven disease primary Sjögren’s syndrome (pSS). Methods: Patients with pSS seropositive or negative for anti-SSA/SSB and controls were included. Protein-based IFN (pIFN) scores were calculated from levels of PD-1, CXCL9 and CXCL10. DNA methylation-based (DNAm) IFN scores were calculated from DNAm levels at RSAD2, IFIT1 and IFI44L . Scores were compared with mRNA-based IFN scores measured by quantitative PCR (qPCR), Nanostring or RNA sequencing (RNAseq). Results: mRNA-based IFN scores displayed strong correlations between B cells and monocytes (r=0.93 and 0.95, p<0.0001) and between qPCR and Nanostring measurements (r=0.92 and 0.92, p<0.0001). The pIFN score in plasma and serum was higher in patients compared with controls (p<0.0001) and correlated well with mRNA-based IFN scores (r=0.62–0.79, p<0.0001), as well as with each other (r=0.94, p<0.0001). Concordance of classification as ‘high’ or ‘low’ IFN signature between the pIFN score and mRNA-based IFN scores ranged from 79.5% to 88.6%, and the pIFN score was effective at classifying patients and controls (area under the curve, AUC=0.89–0.93, p<0.0001). The DNAm IFN score showed strong correlation to the RNAseq IFN score (r=0.84, p<0.0001) and performed well in classifying patients and controls (AUC=0.96, p<0.0001). Conclusions: We describe novel methods of assessing IFN system activity in plasma, serum or DNA samples, which may prove particularly valuable in studies where RNA samples are not available.
- Open Access
- 16 December 2019
- Published by Springer Nature in Biology of Sex Differences
- Vol. 10 (1) , 1-7
Sex differences in clinical presentation of systemic lupus erythematosus
Objective: Systemic lupus erythematosus (SLE) predominantly affects women, but previous studies suggest that men with SLE present a more severe disease phenotype. In this study, we investigated a large and well-characterized patient group with the aim of identifying sex differences in disease manifestations, with a special focus on renal involvement.Methods: We studied a Swedish multi-center SLE cohort including 1226 patients (1060 women and 166 men) with a mean follow-up time of 15.8 ± 13.4 years. Demographic data, disease manifestations including ACR criteria, serology and renal histopathology were investigated. Renal outcome and mortality were analyzed in subcohorts.Results: Female SLE patients presented more often with malar rash (p < 0.0001), photosensitivity (p < 0.0001), oral ulcers (p = 0.01), and arthritis (p = 0.007). Male patients on the other hand presented more often with serositis (p = 0.0003), renal disorder (p < 0.0001), and immunologic disorder (p = 0.04) by the ACR definitions. With regard to renal involvement, women were diagnosed with nephritis at an earlier age (p = 0.006), while men with SLE had an overall higher risk for progression into end-stage renal disease (ESRD) with a hazard ratio (HR) of 5.1 (95% CI, 2.1–12.5). The mortality rate among men with SLE and nephritis compared with women was HR 1.7 (95% CI, 0.8–3.8).Conclusion: SLE shows significant sex-specific features, whereby men are affected by a more severe disease with regard to both renal and extra-renal manifestations. Additionally, men are at a higher risk of developing ESRD which may require an increased awareness and monitoring in clinical practice.
- 16 December 2019
- Published by Springer Nature in Biology of Sex Differences
- Vol. 10 (1) , 1-7
Open AccessSex differences in clinical presentation of systemic lupus erythematosus
Objective: Systemic lupus erythematosus (SLE) predominantly affects women, but previous studies suggest that men with SLE present a more severe disease phenotype. In this study, we investigated a large and well-characterized patient group with the aim of identifying sex differences in disease manifestations, with a special focus on renal involvement.Methods: We studied a Swedish multi-center SLE cohort including 1226 patients (1060 women and 166 men) with a mean follow-up time of 15.8 ± 13.4 years. Demographic data, disease manifestations including ACR criteria, serology and renal histopathology were investigated. Renal outcome and mortality were analyzed in subcohorts.Results: Female SLE patients presented more often with malar rash (p < 0.0001), photosensitivity (p < 0.0001), oral ulcers (p = 0.01), and arthritis (p = 0.007). Male patients on the other hand presented more often with serositis (p = 0.0003), renal disorder (p < 0.0001), and immunologic disorder (p = 0.04) by the ACR definitions. With regard to renal involvement, women were diagnosed with nephritis at an earlier age (p = 0.006), while men with SLE had an overall higher risk for progression into end-stage renal disease (ESRD) with a hazard ratio (HR) of 5.1 (95% CI, 2.1–12.5). The mortality rate among men with SLE and nephritis compared with women was HR 1.7 (95% CI, 0.8–3.8).Conclusion: SLE shows significant sex-specific features, whereby men are affected by a more severe disease with regard to both renal and extra-renal manifestations. Additionally, men are at a higher risk of developing ESRD which may require an increased awareness and monitoring in clinical practice.